These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 818837)

  • 1. [Diabetes therapy in relation to insulin secretion].
    Kränzlin H; Zilker T; Ermler R; Bottermann P
    Verh Dtsch Ges Inn Med; 1975; 81():1478-81. PubMed ID: 818837
    [No Abstract]   [Full Text] [Related]  

  • 2. Glyburide.
    Med Lett Drugs Ther; 1976 Jun; 18(13):54-5. PubMed ID: 819766
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of sulphonylurea on insulin secretion and glucose control in insulin-treated diabetics.
    Ward EA; Ward GM; Turner RC
    Br Med J (Clin Res Ed); 1981 Jul; 283(6286):278. PubMed ID: 6788293
    [No Abstract]   [Full Text] [Related]  

  • 4. [Longtime effect of blood sugar decreasing sulfonamides on glucose tolerance and insulin secretion in adult diabetic patients].
    Haupt E; Cordes U; Petzoldt R; Beyer J; Schöffling K
    Verh Dtsch Ges Inn Med; 1973; 79():1216-20. PubMed ID: 4208216
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metabolic control and insulin secretion in diabetic patients treated with glibenclamide-phenformin combination].
    Fedele D; Tiengo A; Muggeo M; Garotti C; Crepaldi G
    Clin Ter; 1975 Nov; 75(3):273-80. PubMed ID: 819203
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects and limitations of treatment of diabetes. On insulin secretory capacity (author's transl)].
    Kuzuya K
    Horumon To Rinsho; 1980 Feb; 28(2):139-47. PubMed ID: 6769616
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of glibenclamide in the therapy of diabetes].
    Parodi FA
    Minerva Med; 1972 Apr; 63(28):1629-32. PubMed ID: 4623326
    [No Abstract]   [Full Text] [Related]  

  • 8. Symposium on diabetes mellitus and oral hypoglycaemic drugs. Summary.
    Taft P
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:83-5. PubMed ID: 5005135
    [No Abstract]   [Full Text] [Related]  

  • 9. [Glipizide a new oral antidiabetic agent (comprehensive review)].
    Brunová E
    Vnitr Lek; 1976 Jun; 22(6):595-9. PubMed ID: 820071
    [No Abstract]   [Full Text] [Related]  

  • 10. ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.
    Sperling MA
    N Engl J Med; 2006 Aug; 355(5):507-10. PubMed ID: 16885555
    [No Abstract]   [Full Text] [Related]  

  • 11. [Single intravenous glibenclamide-glucose loading as a prediction test (author's transl)].
    Pfeiffer EF; Raptis S; Schröder KE
    Dtsch Med Wochenschr; 1974 Jun; 99(24):1281-94. PubMed ID: 4210532
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of glibenclamide therapy on carbohydrate and lipid metabolism and insulin secretion in patients with glucose tolerance disorders : a 5-year study].
    Ratzmann KP; Witt S; Schulz B; Jahr D; Heinke P
    Z Gesamte Inn Med; 1981 Dec; 36(23):913-7. PubMed ID: 6805141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary clinical experiences and problems of long-term therapy of diabetes mellitus using 2nd generation sulfonylurea derivatives (glibenclamide)].
    Schilling I; Bruns W; Haller H; Mehnert E; Mohnike A; Jutzi E; Schliack V; Schulze J
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:149-5. PubMed ID: 4200337
    [No Abstract]   [Full Text] [Related]  

  • 15. Mild familial diabetes with dominant inheritance.
    Tattersall RB
    Q J Med; 1974 Apr; 43(170):339-57. PubMed ID: 4212169
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quantitative determination of C-peptide and insulin secretion for the evaluation of therapeutic action in manifest diabetes mellitus].
    Wölk I; Zilker T; Schweigart U; Ermler R; Paterek K; Bottermann P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1388-91. PubMed ID: 417495
    [No Abstract]   [Full Text] [Related]  

  • 17. [Insulin secretion and insulin resistance in patients failing to respond to oral hypoglycemic agents].
    Caputo S; Bertoli A; Marini MA; Santini G; Ghirlanda G; Greco AV
    Minerva Endocrinol; 1988; 13(3):167-72. PubMed ID: 3146014
    [No Abstract]   [Full Text] [Related]  

  • 18. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
    Marble A
    Drugs; 1971; 1(2):109-15. PubMed ID: 4999930
    [No Abstract]   [Full Text] [Related]  

  • 19. Sulphonylurea and insulin combination in the treatment of diabetes.
    Fonseca VA
    Br Med J (Clin Res Ed); 1981 Sep; 283(6294):797. PubMed ID: 6791756
    [No Abstract]   [Full Text] [Related]  

  • 20. [New oral antidiabetic agents].
    Doi K
    Nihon Rinsho; 1990 Dec; 48 Suppl():962-73. PubMed ID: 2128351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.